Timothy J Carlson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Timothy J Carlson

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Bioanalysis|September 6, 2012

Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioningGuifen Xu, Jiyun S Chen, Ruta Phadnis, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011

Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)Xiaoshan Min, Stephen T Thibault, Amy C Porter, et al.

Bioorganic & Medicinal Chemistry Letters|March 12, 2011

Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitorsDarin J Gustin, Zhihua Ma, Xiaoshan Min, et al.

Bioorganic & Medicinal Chemistry Letters|November 13, 2013

Metabolism-guided discovery of a potent and orally bioavailable urea-based calcimimetic for the treatment of secondary hyperparathyroidismPaul M Wehn, Paul E Harrington, Timothy J Carlson, et al.

Bioorganic & Medicinal Chemistry Letters|July 13, 2013

Structure guided design of a series of sphingosine kinase (SphK) inhibitorsDarin J Gustin, Yihong Li, Matthew L Brown, et al.

Journal of Medicinal Chemistry|March 20, 2014

Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3Zhihong Li, Xianghong Wang, John Eksterowicz, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Bioanalysis|September 6, 2012

Application of DBS sampling in combination with LC-MS/MS for pharmacokinetic evaluation of a compound with species-specific blood-to-plasma partitioningGuifen Xu, Jiyun S Chen, Ruta Phadnis, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 20, 2011

Discovery and molecular basis of potent noncovalent inhibitors of fatty acid amide hydrolase (FAAH)Xiaoshan Min, Stephen T Thibault, Amy C Porter, et al.

Bioorganic & Medicinal Chemistry Letters|March 12, 2011

Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitorsDarin J Gustin, Zhihua Ma, Xiaoshan Min, et al.

Bioorganic & Medicinal Chemistry Letters|November 13, 2013

Metabolism-guided discovery of a potent and orally bioavailable urea-based calcimimetic for the treatment of secondary hyperparathyroidismPaul M Wehn, Paul E Harrington, Timothy J Carlson, et al.

Bioorganic & Medicinal Chemistry Letters|July 13, 2013

Structure guided design of a series of sphingosine kinase (SphK) inhibitorsDarin J Gustin, Yihong Li, Matthew L Brown, et al.

Journal of Medicinal Chemistry|March 20, 2014

Discovery of AMG 925, a FLT3 and CDK4 dual kinase inhibitor with preferential affinity for the activated state of FLT3Zhihong Li, Xianghong Wang, John Eksterowicz, et al.

Pageof 2